Braveheart
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Letterman Dr Ste A, San Francisco, Cal...Phone Number
(415) 707-6312Website
braveheart.bioRevenue
-Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Braveheart
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is backed by experienced life science investors including Andreessen Horowitz (a16z Bio + Health), Forbion, OrbiMed, Enavate Sciences (a platform of Patient Square Capital), and Frazier Life Sciences.Explore more
Braveheart Org Chart
Ed
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Braveheart your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Braveheart recently announced quarterly report
Click to see if Braveheart had a recent Job posting/layoffs
Braveheart, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Braveheart
Funding: Get notified immidiatlly once Braveheart has new funding data
Check if Braveheart has recently received funding, and reach out quickly before it becomes old news!
Check out if Braveheart is spiking on competitors!
Product Launch: Get notified when Braveheart launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Braveheart as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Braveheart is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Braveheart is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Braveheart.
Braveheart financials insights
Gather financial insights about Braveheart, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$185M
Braveheart Tech Stack
A closer look at the technologies used by Braveheart
See more technologies
Most Recent Scoops
Hiring Plans
Braveheart Bio has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: ICH Guidelines, Pharmaceuticals, Health Care Industry, and Clinical Trials.
Hiring Plans
Open Position
Open Position
Open Position
Open Position
Braveheart News & Media
Hengrui Pharma and Braveheart Bio Announce Positive Phase 2 Results with HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy
Results of dose-ranging study suggest potential for best-in-class clinical profile across efficacy, safety and ease of use, including simplified dosing regimen with minimal to no titration necessary HRS-1893 treatment resulted in rapid and substantial reductions in left ventricular...Braveheart Bio Appoints Emil deGoma, M.D., as Chief Medical Officer
Appointment strengthens medical leadership as company advances development of BHB-1893 Company progressing toward planned initiation of a global pivotal trial in obstructive hypertrophic cardiomyopathy in 2026 SAN FRANCISCO, March 26, 2026 /PRNewswire/ -- Braveheart Bio, a clinical-stage...Braveheart Bio to Participate in TD Cowen 46th Annual Health Care Conference
SAN FRANCISCO, Feb. 23, 2026 /PRNewswire/ -- Braveheart Bio, a clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions, today announced that it will participate in the TD Cowen 46th Annual Health Care Conference taking...Braveheart Bio Announces Senior Leadership Appointments to Strengthen Scientific and Operational Capabilities While Advancing Global Phase 3 Development
Marc Evanchik promoted to Chief Scientific Officer to lead clinical development, research and scientific strategy Brittany de Temple joins as Senior Vice President of Development Operations to prepare for expanded clinical operations Company advancing toward planned initiation of a global...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Braveheart
Sign Up For FreeTo access detailed company insights
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is backed by experienced life science investors including Andreessen Horowitz (a16z Bio + Health), Forbion, OrbiMed, Enavate Sciences (a platform of Patient Square Capital), and Frazier Life... Read More
